US Stock MarketDetailed Quotes

RLMD Relmada Therapeutics

Watchlist
  • 0.670
  • -2.100-75.81%
Trading Dec 4 10:46 ET
20.22MMarket Cap-234P/E (TTM)

Relmada Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
1.39%23.01M
-27.69%18.82M
-18.35%22.99M
-35.69%103.7M
-30.68%26.83M
-41.42%22.69M
-42.81%26.03M
-26.49%28.15M
28.28%161.25M
13.22%38.7M
Selling and administrative expenses
-3.10%11.86M
-34.09%8.1M
-21.23%9.68M
2.02%48.89M
2.06%12.08M
49.10%12.24M
-15.84%12.29M
-7.47%12.29M
36.61%47.93M
32.83%11.83M
-General and administrative expense
-3.10%11.86M
-34.09%8.1M
-21.23%9.68M
2.02%48.89M
2.06%12.08M
49.10%12.24M
-15.84%12.29M
-7.47%12.29M
36.61%47.93M
32.83%11.83M
Research and development costs
6.65%11.15M
-21.97%10.72M
-16.11%13.31M
-51.64%54.81M
-45.10%14.75M
-65.76%10.45M
-55.55%13.74M
-36.59%15.86M
25.05%113.32M
6.31%26.87M
Operating profit
-1.39%-23.01M
27.69%-18.82M
18.35%-22.99M
35.69%-103.7M
30.68%-26.83M
41.42%-22.69M
42.81%-26.03M
26.49%-28.15M
-28.28%-161.25M
-13.22%-38.7M
Net non-operating interest income expense
-35.19%856.48K
-29.37%963.01K
-12.57%1.06M
93.72%5.15M
12.98%1.26M
59.67%1.32M
252.00%1.36M
266.01%1.21M
121.79%2.66M
602.52%1.11M
Non-operating interest income
-35.19%856.48K
-29.37%963.01K
-12.57%1.06M
93.72%5.15M
12.98%1.26M
59.67%1.32M
252.00%1.36M
266.01%1.21M
121.79%2.66M
602.52%1.11M
Other net income (expense)
167.59%426.39K
113.70%87.65K
-83.37%103.85K
-115.60%-241.16K
213.60%404.94K
58.20%-630.86K
-112.32%-639.63K
135.11%624.4K
223.92%1.55M
-0.59%-356.47K
Gain on sale of security
167.59%426.39K
113.70%87.65K
-83.37%103.85K
94.98%-241.16K
213.60%404.94K
58.20%-630.86K
44.95%-639.63K
135.11%624.4K
-285.27%-4.81M
-0.59%-356.47K
Other non- operating income (expenses)
----
----
----
----
----
----
----
----
--6.35M
--0
Income before tax
1.25%-21.73M
29.78%-17.77M
17.07%-21.83M
37.09%-98.79M
33.68%-25.17M
44.18%-22M
36.64%-25.3M
33.78%-26.32M
-24.88%-157.04M
-10.37%-37.94M
Income tax
Net income
1.25%-21.73M
29.78%-17.77M
17.07%-21.83M
37.09%-98.79M
33.68%-25.17M
44.18%-22M
36.64%-25.3M
33.78%-26.32M
-24.88%-157.04M
-10.37%-37.94M
Net income continuous Operations
1.25%-21.73M
29.78%-17.77M
17.07%-21.83M
37.09%-98.79M
33.68%-25.17M
44.18%-22M
36.64%-25.3M
33.78%-26.32M
-24.88%-157.04M
-10.37%-37.94M
Minority interest income
Net income attributable to the parent company
1.25%-21.73M
29.78%-17.77M
17.07%-21.83M
37.09%-98.79M
33.68%-25.17M
44.18%-22M
36.64%-25.3M
33.78%-26.32M
-24.88%-157.04M
-10.37%-37.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
1.25%-21.73M
29.78%-17.77M
17.07%-21.83M
37.09%-98.79M
33.68%-25.17M
44.18%-22M
36.64%-25.3M
33.78%-26.32M
-24.88%-157.04M
-10.37%-37.94M
Basic earnings per share
1.37%-0.72
29.76%-0.59
17.24%-0.72
38.11%-3.28
34.13%-0.83
44.27%-0.73
36.84%-0.84
37.86%-0.87
25.98%-5.3
30.00%-1.26
Diluted earnings per share
1.37%-0.72
29.76%-0.59
17.24%-0.72
38.11%-3.28
34.13%-0.83
44.27%-0.73
36.84%-0.84
37.86%-0.87
25.98%-5.3
30.00%-1.26
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 1.39%23.01M-27.69%18.82M-18.35%22.99M-35.69%103.7M-30.68%26.83M-41.42%22.69M-42.81%26.03M-26.49%28.15M28.28%161.25M13.22%38.7M
Selling and administrative expenses -3.10%11.86M-34.09%8.1M-21.23%9.68M2.02%48.89M2.06%12.08M49.10%12.24M-15.84%12.29M-7.47%12.29M36.61%47.93M32.83%11.83M
-General and administrative expense -3.10%11.86M-34.09%8.1M-21.23%9.68M2.02%48.89M2.06%12.08M49.10%12.24M-15.84%12.29M-7.47%12.29M36.61%47.93M32.83%11.83M
Research and development costs 6.65%11.15M-21.97%10.72M-16.11%13.31M-51.64%54.81M-45.10%14.75M-65.76%10.45M-55.55%13.74M-36.59%15.86M25.05%113.32M6.31%26.87M
Operating profit -1.39%-23.01M27.69%-18.82M18.35%-22.99M35.69%-103.7M30.68%-26.83M41.42%-22.69M42.81%-26.03M26.49%-28.15M-28.28%-161.25M-13.22%-38.7M
Net non-operating interest income expense -35.19%856.48K-29.37%963.01K-12.57%1.06M93.72%5.15M12.98%1.26M59.67%1.32M252.00%1.36M266.01%1.21M121.79%2.66M602.52%1.11M
Non-operating interest income -35.19%856.48K-29.37%963.01K-12.57%1.06M93.72%5.15M12.98%1.26M59.67%1.32M252.00%1.36M266.01%1.21M121.79%2.66M602.52%1.11M
Other net income (expense) 167.59%426.39K113.70%87.65K-83.37%103.85K-115.60%-241.16K213.60%404.94K58.20%-630.86K-112.32%-639.63K135.11%624.4K223.92%1.55M-0.59%-356.47K
Gain on sale of security 167.59%426.39K113.70%87.65K-83.37%103.85K94.98%-241.16K213.60%404.94K58.20%-630.86K44.95%-639.63K135.11%624.4K-285.27%-4.81M-0.59%-356.47K
Other non- operating income (expenses) ----------------------------------6.35M--0
Income before tax 1.25%-21.73M29.78%-17.77M17.07%-21.83M37.09%-98.79M33.68%-25.17M44.18%-22M36.64%-25.3M33.78%-26.32M-24.88%-157.04M-10.37%-37.94M
Income tax
Net income 1.25%-21.73M29.78%-17.77M17.07%-21.83M37.09%-98.79M33.68%-25.17M44.18%-22M36.64%-25.3M33.78%-26.32M-24.88%-157.04M-10.37%-37.94M
Net income continuous Operations 1.25%-21.73M29.78%-17.77M17.07%-21.83M37.09%-98.79M33.68%-25.17M44.18%-22M36.64%-25.3M33.78%-26.32M-24.88%-157.04M-10.37%-37.94M
Minority interest income
Net income attributable to the parent company 1.25%-21.73M29.78%-17.77M17.07%-21.83M37.09%-98.79M33.68%-25.17M44.18%-22M36.64%-25.3M33.78%-26.32M-24.88%-157.04M-10.37%-37.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 1.25%-21.73M29.78%-17.77M17.07%-21.83M37.09%-98.79M33.68%-25.17M44.18%-22M36.64%-25.3M33.78%-26.32M-24.88%-157.04M-10.37%-37.94M
Basic earnings per share 1.37%-0.7229.76%-0.5917.24%-0.7238.11%-3.2834.13%-0.8344.27%-0.7336.84%-0.8437.86%-0.8725.98%-5.330.00%-1.26
Diluted earnings per share 1.37%-0.7229.76%-0.5917.24%-0.7238.11%-3.2834.13%-0.8344.27%-0.7336.84%-0.8437.86%-0.8725.98%-5.330.00%-1.26
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Symbol Mini Chart % Chg
Bitdeer Technologies
BTDR
+14.27%
NEPTUNE DIGITAL ASSETS CORP
NPPTF
+9.58%
Canaan
CAN
+11.05%
Bit Digital
BTBT
+7.80%
Hut 8
HUT
+8.02%

Unlock the Full List